Amundi

Position in INSM — INSMED Inc

CIK 1330387 Paris, I0

Position in INSM

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$51,979,914

-$79,649,924 QoQ

Shares Held

487,525

-39.4% QoQ

Ownership

0.223%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#80

of 665 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Amundi holds $2,427,056,148 across 70 Biotechnology names. INSM ranks #9 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,546,509	$768,197,412
2	REGN	Regeneron Pharmaceuticals, Inc.	1,013,540	$631,982,729
3	RPRX	Royalty Pharma plc	3,723,864	$208,797,052
4	ALNY	Alnylam Pharmaceuticals, Inc.	617,471	$185,877,294
5	INCY	Incyte Corp	1,181,498	$133,934,612
6	TECH	BIO-TECHNE Corp	1,827,241	$129,094,576
7	MRNA	Moderna, Inc.	888,779	$62,241,193
8	ARGX	Argenx SE	65,122	$60,418,237

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$51,979,914	487,525	-39.4%	Shares	Defined	2026-08-11
2026-03-31	$131,629,838	804,977	-12.2%	Shares	Defined	2026-05-18
2025-12-31	$159,594,331	916,998	+189.2%	Shares	Defined	2026-02-17
2025-09-30	$45,664,994	317,096	+2657.6%	Shares	Defined	2025-11-14
2025-06-30	$1,157,259	11,499	+21194.4%	Shares	Defined	2025-08-13
2025-03-31	$4,119	54	+28.6%	Shares	Defined	2025-05-15
2024-12-31	$2,899	42	-99.1%	Shares	Defined	2025-02-07
2022-09-30	$105,933	4,918	0.0%	Shares	Defined	2022-11-14
2022-06-30	$96,982	4,918	0.0%	Shares	Defined	2022-09-02
2022-03-31	$115,573	4,918	0.0%	Shares	Defined	2022-05-16
2021-12-31	$133,966	4,918	-30.1%	Shares	Defined	2022-02-14
2021-09-30	$193,771	7,036	0.0%	Shares	Defined	2021-11-15
2021-06-30	$200,244	7,036	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.